JP2008537546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008537546A5 JP2008537546A5 JP2008502334A JP2008502334A JP2008537546A5 JP 2008537546 A5 JP2008537546 A5 JP 2008537546A5 JP 2008502334 A JP2008502334 A JP 2008502334A JP 2008502334 A JP2008502334 A JP 2008502334A JP 2008537546 A5 JP2008537546 A5 JP 2008537546A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- tumor
- associated antigen
- antibody
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005013846A DE102005013846A1 (de) | 2005-03-24 | 2005-03-24 | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| DE102005013846.2 | 2005-03-24 | ||
| PCT/EP2006/002695 WO2006100089A2 (de) | 2005-03-24 | 2006-03-23 | Identifizierung von oberflächen-assoziierten antigenen für die tumordiagnose und -therapie |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012083549A Division JP5731436B2 (ja) | 2005-03-24 | 2012-04-02 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2012258431A Division JP5779167B2 (ja) | 2005-03-24 | 2012-11-27 | 腫瘍診断と治療のための表面関連抗原の同定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008537546A JP2008537546A (ja) | 2008-09-18 |
| JP2008537546A5 true JP2008537546A5 (enExample) | 2009-04-30 |
| JP5253999B2 JP5253999B2 (ja) | 2013-07-31 |
Family
ID=36613498
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008502334A Expired - Lifetime JP5253999B2 (ja) | 2005-03-24 | 2006-03-23 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2012083549A Expired - Lifetime JP5731436B2 (ja) | 2005-03-24 | 2012-04-02 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2012258431A Expired - Lifetime JP5779167B2 (ja) | 2005-03-24 | 2012-11-27 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2014005640A Expired - Lifetime JP5922159B2 (ja) | 2005-03-24 | 2014-01-16 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2016032631A Expired - Lifetime JP6174177B2 (ja) | 2005-03-24 | 2016-02-24 | 腫瘍診断と治療のための表面関連抗原の同定 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012083549A Expired - Lifetime JP5731436B2 (ja) | 2005-03-24 | 2012-04-02 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2012258431A Expired - Lifetime JP5779167B2 (ja) | 2005-03-24 | 2012-11-27 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2014005640A Expired - Lifetime JP5922159B2 (ja) | 2005-03-24 | 2014-01-16 | 腫瘍診断と治療のための表面関連抗原の同定 |
| JP2016032631A Expired - Lifetime JP6174177B2 (ja) | 2005-03-24 | 2016-02-24 | 腫瘍診断と治療のための表面関連抗原の同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US9090940B2 (enExample) |
| EP (5) | EP2314310A3 (enExample) |
| JP (5) | JP5253999B2 (enExample) |
| DE (1) | DE102005013846A1 (enExample) |
| ES (1) | ES2537319T3 (enExample) |
| WO (1) | WO2006100089A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005013846A1 (de) | 2005-03-24 | 2006-10-05 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| DE102006060824B4 (de) * | 2006-12-21 | 2011-06-01 | Johannes-Gutenberg-Universität Mainz | Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten |
| EP2060583A1 (en) * | 2007-10-23 | 2009-05-20 | Ganymed Pharmaceuticals AG | Identification of tumor-associated markers for diagnosis and therapy |
| EP2249159A1 (en) * | 2009-04-29 | 2010-11-10 | Ganymed Pharmaceuticals AG | Identification of tumor-associated markers for diagnosis and therapy |
| EP4154900B1 (en) | 2009-07-29 | 2024-08-28 | Kai Pharmaceuticals, Inc. | Therapeutic agents for reducing parathyroid hormone levels |
| US8486657B2 (en) * | 2010-03-22 | 2013-07-16 | Xiaohong Cai | Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers |
| TW201302800A (zh) | 2011-06-10 | 2013-01-16 | 腫瘤療法 科學股份有限公司 | Ｓｅｍａ５ｂ胜肽及含其之疫苗 |
| CN105814073A (zh) * | 2012-12-04 | 2016-07-27 | 肿瘤疗法科学股份有限公司 | Sema5b肽和含有sema5b肽的疫苗 |
| JP6164759B2 (ja) | 2013-11-21 | 2017-07-19 | Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 | Ｔ細胞受容体およびｂ細胞受容体レパトアの解析システムならびにその治療および診断への利用 |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| CN107530376A (zh) | 2015-02-18 | 2018-01-02 | 恩立夫克治疗有限责任公司 | 用于癌症治疗的联合免疫疗法和细胞因子控制疗法 |
| IL287500B2 (en) | 2015-04-21 | 2023-12-01 | Enlivex Therapeutics Rdo Ltd | Therapeutic pooled blood apoptotic cell preparations and uses thereof |
| GB201520564D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| KR102883915B1 (ko) | 2015-12-16 | 2025-11-18 | 시애틀 프로젝트 코포레이션 | 신생항원 동정, 제조, 및 용도 |
| WO2017123808A1 (en) | 2016-01-15 | 2017-07-20 | The J. David Gladstone Institutes | Methods of treating disease by metabolic control of t-cell differentiation |
| CA3014885A1 (en) | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
| CN119080881A (zh) * | 2017-07-07 | 2024-12-06 | 伊玛提克斯生物技术有限公司 | 用于肺癌(包括nsclc、sclc和其他癌症)免疫治疗的新型肽和肽组合物 |
| WO2019075112A1 (en) | 2017-10-10 | 2019-04-18 | Gritstone Oncology, Inc. | IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS |
| KR20260008173A (ko) | 2017-11-22 | 2026-01-15 | 시애틀 프로젝트 코포레이션 | 신생항원에 대한 접합 에피토프 제시 감소 |
| US20240261333A1 (en) * | 2021-06-03 | 2024-08-08 | The Broad Institute, Inc. | Novel targets for enhancing anti-tumor immunity |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2191A (en) | 1841-07-23 | Constructing the surgical instrument denominated the | ||
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| CA2243235C (en) | 1996-01-17 | 2010-08-10 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| JP2002514073A (ja) * | 1997-02-24 | 2002-05-14 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| WO1998055508A2 (en) * | 1997-06-03 | 1998-12-10 | Sagami Chemical Research Center | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| EP1144444A3 (en) | 1998-12-22 | 2002-01-02 | Genset | Dnas encoding proteins with signal sequences |
| US20030204075A9 (en) | 1999-08-09 | 2003-10-30 | The Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| AU2001288237A1 (en) | 2000-08-07 | 2002-02-18 | Curagen Corporation | Proteins and nucleic acids encoding g-protein coupled receptors |
| USH2191H1 (en) | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
| JP2005527180A (ja) * | 2001-04-18 | 2005-09-15 | プロテイン デザイン ラブス， インコーポレイテッド | 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法 |
| DE60239535D1 (de) * | 2001-06-18 | 2011-05-05 | Rosetta Inpharmatics Llc | Diagnose und prognose von brustkrebspatientinnen |
| US7171311B2 (en) * | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
| US20040076955A1 (en) | 2001-07-03 | 2004-04-22 | Eos Biotechnology, Inc. | Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| DE10211088A1 (de) * | 2002-03-13 | 2003-09-25 | Ugur Sahin | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| AU2003263660A1 (en) * | 2003-08-29 | 2005-03-16 | Pantarhei Bioscience B.V. | Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood |
| DE10344799A1 (de) * | 2003-09-26 | 2005-04-14 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| DE102005013846A1 (de) | 2005-03-24 | 2006-10-05 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
-
2005
- 2005-03-24 DE DE102005013846A patent/DE102005013846A1/de not_active Ceased
-
2006
- 2006-03-23 JP JP2008502334A patent/JP5253999B2/ja not_active Expired - Lifetime
- 2006-03-23 EP EP10010915A patent/EP2314310A3/de not_active Withdrawn
- 2006-03-23 WO PCT/EP2006/002695 patent/WO2006100089A2/de not_active Ceased
- 2006-03-23 EP EP06723678.6A patent/EP1861118B1/de not_active Expired - Lifetime
- 2006-03-23 EP EP10010913A patent/EP2311487A3/de not_active Withdrawn
- 2006-03-23 ES ES06723678.6T patent/ES2537319T3/es not_active Expired - Lifetime
- 2006-03-23 US US11/886,758 patent/US9090940B2/en active Active
- 2006-03-23 EP EP10010914A patent/EP2314309A3/de not_active Withdrawn
- 2006-03-23 EP EP20100010912 patent/EP2327417B1/de not_active Expired - Lifetime
-
2012
- 2012-04-02 JP JP2012083549A patent/JP5731436B2/ja not_active Expired - Lifetime
- 2012-11-27 JP JP2012258431A patent/JP5779167B2/ja not_active Expired - Lifetime
-
2013
- 2013-04-17 US US13/864,411 patent/US9194004B2/en active Active
-
2014
- 2014-01-16 JP JP2014005640A patent/JP5922159B2/ja not_active Expired - Lifetime
-
2015
- 2015-06-19 US US14/744,845 patent/US10036753B2/en not_active Expired - Lifetime
-
2016
- 2016-02-24 JP JP2016032631A patent/JP6174177B2/ja not_active Expired - Lifetime
- 2016-03-07 US US14/887,979 patent/US10302647B2/en not_active Expired - Lifetime